Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
1.
J Proteome Res ; 10(7): 2896-904, 2011 Jul 01.
Article in English | MEDLINE | ID: mdl-21520941

ABSTRACT

In shotgun proteomics, protein identification by tandem mass spectrometry relies on bioinformatics tools. Despite recent improvements in identification algorithms, a significant number of high quality spectra remain unidentified for various reasons. Here we present ScanRanker, an open-source tool that evaluates the quality of tandem mass spectra via sequence tagging with reliable performance in data from different instruments. The superior performance of ScanRanker enables it not only to find unassigned high quality spectra that evade identification through database search but also to select spectra for de novo sequencing and cross-linking analysis. In addition, we demonstrate that the distribution of ScanRanker scores predicts the richness of identifiable spectra among multiple LC-MS/MS runs in an experiment, and ScanRanker scores assist the process of peptide assignment validation to increase confident spectrum identifications. The source code and executable versions of ScanRanker are available from http://fenchurch.mc.vanderbilt.edu.


Subject(s)
Algorithms , Computational Biology , Peptide Fragments/analysis , Proteins/analysis , Proteomics/methods , Tandem Mass Spectrometry/methods , Animals , Chromatography, Liquid , Databases, Protein , Humans , Peptide Fragments/chemistry , Proteins/chemistry , Research Design , Sequence Analysis, Protein
2.
Mol Cell Proteomics ; 6(1): 150-69, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17028091

ABSTRACT

Multivariable DIGE/MS was used to investigate proteins altered in expression and/or post-translational modification in response to activation of transforming growth factor (TGF)-beta receptors in MCF10A mammary epithelial cells overexpressing the HER2/Neu (ErbB2) oncogene. Proteome changes were monitored in response to exogenous TGF-beta over time (0, 8, 24, and 40 h), and proteins were resolved using medium range (pH 4-7) and narrow range (pH 5.3-6.5) isoelectric focusing combined with up to 2 mg of protein to allow inspection of lower abundance proteins. Triplicate samples were prepared independently and analyzed together across multiple DIGE gels using a pooled sample internal standard to quantify expression changes with statistical confidence. Unsupervised principle component analysis and hierarchical clustering of the individual DIGE proteome expression maps provided independent confirmation of distinct expression patterns from the individual experiments and demonstrated high reproducibility between replicate samples. Fifty-nine proteins (including some isoforms) that exhibited significant kinetic expression changes were identified using mass spectrometry and database interrogation and were mapped to existing biological networks involved in TGF-beta signaling. Several proteins with a potential role in breast cancer, such as maspin and cathepsin D, were identified as novel molecules associated with TGF-beta signaling.


Subject(s)
Electrophoresis, Gel, Two-Dimensional/methods , Mass Spectrometry/methods , Receptor, ErbB-2/metabolism , Signal Transduction/drug effects , Transforming Growth Factor beta1/pharmacology , Amino Acid Sequence , Cathepsin D/chemistry , Cathepsin D/metabolism , Cluster Analysis , Genes, Tumor Suppressor , Humans , Hydrogen-Ion Concentration , Metabolic Networks and Pathways , Molecular Sequence Data , Multivariate Analysis , Principal Component Analysis , Proteome/chemistry , Reproducibility of Results , Serpins/chemistry , Serpins/metabolism , Time Factors
3.
J Cell Physiol ; 210(3): 740-9, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17133351

ABSTRACT

Activating mutations of the RAS family of small GTPases are among the most common genetic events in human tumorigenesis. Constitutive activation of the three canonical family members, KRAS, NRAS, and HRAS segregate strongly by tissue type. Of these, KRAS mutations predominate in human tumors, including those arising from the colon and lung. We sought to compare the oncogenic contributions of different RAS isoforms in a comparable genetic setting and to explore downstream molecular changes that may explain the apparent differential oncogenic effects of the various RAS family members. We utilized colorectal cancer cell lines characterized by oncogenic KRAS in parallel with isogenically derived lines in which the mutant allele has been disrupted. We additionally attempted to reconstitute the isogenic derivatives with oncogenic forms of other RAS family members and analyze them in parallel. Pairwise analysis of HCT 116 and DLD-1 cell lines as well as their isogenic derivatives reveals distinct K-RAS(G13D) signatures despite the genetic similarities of these cell lines. In DLD-1, for example, oncogenic K-RAS enhances the motility of these cells by downregulation of Rap1 activity, yet is not associated with increased ERK1/2 phosphorylation. In HCT 116, however, ERK1/2 phosphorylation is elevated relative to the isogenic derivative, but Rap1 activity is unchanged. K-RAS is uniquely oncogenic in the colonic epithelium, though the molecular aspects of its oncogenic contribution are not necessarily conserved across cell lines. We therefore conclude that the oncogenic contribution of K-RAS is a function of its multifaceted functionality and is highly context-dependent.


Subject(s)
Colon/metabolism , Colorectal Neoplasms/genetics , Genes, ras/genetics , Intestinal Mucosa/metabolism , Cell Line, Tumor , Cell Transformation, Neoplastic/genetics , Colon/pathology , Colorectal Neoplasms/physiopathology , Gene Expression Regulation, Neoplastic , Genes, ras/physiology , Humans , Intestinal Mucosa/pathology , Isoenzymes , MAP Kinase Kinase Kinases/genetics , MAP Kinase Kinase Kinases/metabolism , Mitogen-Activated Protein Kinase 3/genetics , Mitogen-Activated Protein Kinase 3/metabolism , Signal Transduction/physiology , rap1 GTP-Binding Proteins/genetics , rap1 GTP-Binding Proteins/metabolism
4.
PLoS Pathog ; 2(8): e87, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16933993

ABSTRACT

Staphylococcus aureus pathogenesis is significantly influenced by the iron status of the host. However, the regulatory impact of host iron sources on S. aureus gene expression remains unknown. In this study, we combine multivariable difference gel electrophoresis and mass spectrometry with multivariate statistical analyses to systematically cluster cellular protein response across distinct iron-exposure conditions. Quadruplicate samples were simultaneously analyzed for alterations in protein abundance and/or post-translational modification state in response to environmental (iron chelation, hemin treatment) or genetic (Deltafur) alterations in bacterial iron exposure. We identified 120 proteins representing several coordinated biochemical pathways that are affected by changes in iron-exposure status. Highlighted in these experiments is the identification of the heme-regulated transport system (HrtAB), a novel transport system which plays a critical role in staphylococcal heme metabolism. Further, we show that regulated overproduction of acidic end-products brought on by iron starvation decreases local pH resulting in the release of iron from the host iron-sequestering protein transferrin. These findings reveal novel strategies used by S. aureus to acquire scarce nutrients in the hostile host environment and begin to define the iron and heme-dependent regulons of S. aureus.


Subject(s)
Bacterial Proteins/metabolism , Gene Expression Regulation, Bacterial , Iron/metabolism , Repressor Proteins/metabolism , Staphylococcus aureus/metabolism , Bacterial Proteins/genetics , Biological Availability , Electrophoresis, Gel, Two-Dimensional , Heme/metabolism , Hydrogen-Ion Concentration , Iron Deficiencies , Iron-Binding Proteins/genetics , Iron-Binding Proteins/metabolism , Mass Spectrometry , Proteomics , Repressor Proteins/genetics , Staphylococcus aureus/genetics , Staphylococcus aureus/growth & development , Transferrin/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL